Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 10,000 shares at $29.53 ($297K) on 2014-10-01, disclosed to the SEC on 2014-10-01.
Scheduled sale ($297k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.53 | 4,100 | $121K | 40.8% |
| 2 | $29.53 | 4,200 | $124K | 41.8% |
| 3 | $30.27 | 800 | $24K | 8.2% |
| 4 | $30.28 | 900 | $27K | 9.2% |
| Total | $29.66 avg | 10,000 | $297K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |